Annexon biosciences to host conference call and webcast to discuss gbs phase 3 data

Brisbane, calif., june 03, 2024 (globe newswire) -- annexon, inc. (nasdaq: annx), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that it will host a conference call and webcast on tuesday, june 4, 2024, at 8:30 a.m.
ANNX Ratings Summary
ANNX Quant Ranking